Interventions for valvular disease and heart failure

Early outcomes of transcarotid access for transcatheter aortic valve implantation

EuroIntervention 2020;15:e1332-e1334. DOI: 10.4244/EIJ-D-18-01192

Jean-Philippe Verhoye
Jean-Philippe Verhoye1, MD, PhD; Réda Belhaj Soulami1, MD; Jacques Tomasi1, MD; Dario Di Perna1, MD; Guillaume Leurent2, MD; Sébastien Rosier3, MD; Sébastien Biedermann3, MD; Amedeo Anselmi1, MD, PhD
1. Division of Thoracic and Cardiovascular Surgery, Pontchaillou University Hospital, Rennes, France; 2. Division of Cardiology, Pontchaillou University Hospital, Rennes, France; 3. Division of Cardiac Anesthesia, Pontchaillou University Hospital, Rennes, France


A substantial proportion of candidates for transcatheter aortic valve implantation (TAVI) still present a contraindication to transfemoral (TF) access. Furthermore, major vascular and bleeding complications remain concerning issues in patients undergoing TF TAVI, with an accompanying significant impact on mortality and morbidity.

Transcarotid (TC) TAVI was initially described by Modine et al1; it has subsequently proven to be reproducible2,3 and is associated with significant potential regarding early morbidity and hospital stay. Nonetheless, it still has not achieved broad consensus.

In this report, we sought to present a single-centre experience of TC TAVI, with particular focus ...

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Impact of implant depth on hydrodynamic function of the ALLEGRA bioprosthesis in valve-in-valve interventions

Latest news